不同剂量瑞马唑仑用于全身麻醉诱导的临床效果

摘要
图/表
参考文献(17)
相关文章 (15)

全文: PDF (0 KB) HTML (36 KB)
输出: BibTeX | EndNote (RIS)

摘要目的探讨不同剂量瑞马唑仑用于全身麻醉诱导的临床效果。方法选取2021年1月至3月连云港市第一人民医院收治的100 例择期行全身麻醉气管插管手术患者作为研究对象，按照随机数字表法分为A 组（25 例）、B 组（25 例）、C 组（25 例）和D 组（25 例）。四组全麻诱导均采用舒芬太尼和顺式阿曲库铵，在此基础上A 组使用丙泊酚2 mg/kg，B 组使用瑞马唑仑0.2 mg/kg、C 组使用瑞马唑仑0.3 mg/kg、D 组使用瑞马唑仑0.4 mg/kg。比较四组入手术室时（T0）、给药后脑电双频指数（BIS）≤60 时（T1）、气管插管时（T2）的平均动脉压（MAP）和心率（HR）；比较四组的给药起效时间和追加给药次数；比较四组的不良反应发生情况；术后第1 天对患者进行术中知晓评估。结果 T1 时四组的MAP 和HR 低于同组T0 时间点，差异有统计学意义（P＜0.05），T0、T1 和T2 时四组的MAP 和HR组间比较，差异无统计学意义（P＞0.05）。B、C 和D 组的药物起效时间长于A 组，B 组的起效时间长于C 和D 组，C组的起效时间长于D 组，差异有统计学意义（P＜0.05）。B 组追加给药次数多于A、C 和D 组，差异有统计学意义（P＜0.008）。B、C、D 三组的不良反应总发生率低于A 组，差异有统计学意义（P＜0.008）。四组患者均未见术中知晓的发生。结论瑞马唑仑可有效、安全地应用于气管插管全身麻醉的麻醉诱导，且剂量为0.3 mg/kg 效果及安全性较佳。

	服务

	把本文推荐给朋友
	加入我的书架
	加入引用管理器
	E-mail Alert
	RSS
	作者相关文章
	刘东志
	孙成亮
	赵志斌

关键词 ：瑞马唑仑, 丙泊酚, 麻醉诱导, 气管插管, 脑电双频指数

Abstract：Objective To investigate the clinical effect of different doses of Remazolam on induction of general anesthesia. Methods A total of 100 patients undergoing elective tracheal intubation under general anesthesia admitted to the First People′s Hospital of Lianyungang from January to March 2021 were selected as the research subjects, and they were divided into group A (25 cases), group B (25 cases), group C (25 cases) and group D (25 cases) according to random number table method. Sufentanil and Cisatracurium were used for induction of general anesthesia in all four groups. On this basis, group A was treated with 2 mg/kg Propofol, group B was treated with 0.2 mg/kg Remazolam,group C was treated with 0.3 mg/kg Remazolam, and group D was treated with 0.4 mg/kg Remazolam. The mean arterial pressure (MAP) and heart rate (HR) of the four groups were compared at entry into the operating room (T0), bispectral index of electroencephalogram after drug administration (BIS) ≤60 (T1) and endotracheal intubation (T2). The onset time and times of additional administration were compared among the four groups. The incidence of adverse reactions in four groups was compared. Intraoperative awareness assessment was performed 1 day after surgery. Results At T1, MAP and HR of the four groups were lower than those of the same group at T0, the difference was statistically significant (P＜0.05), but there was no significant difference between MAP and HR of the four groups at T0, T1 and T2 (P＞0.05). The onset time of drugs in groups B, C and D was longer than that in group A, group B was longer than that in groups C and D, and group C was longer than that in group D, with statistical significance (P＜0.05). The frequency of additional administration in group B was higher than that in groups A, C and D, and the difference was statistically significant (P＜0.008). The total incidence of adverse reaction in group B, C and D was lower than that in group A, and the differences were statistically significant (P＜0.008). None of the patients in the four groups had any known intraoperative occurrence. Conclusion Remazolam can be used effectively and safely in induction of general anesthesia with tracheal intubation, and the effect and safety of 0.3 mg/kg is better.

Key words： Remazolam Propofol Anesthesia induction Trachea cannula Bispectral index

引用本文:

刘东志；孙成亮；赵志斌. 不同剂量瑞马唑仑用于全身麻醉诱导的临床效果[J]. 中国当代医药, 2021, 28(28): 122-125.
LIU Dong-zhi；SUN Cheng-liang；ZHAO Zhi-bin. Clinical effects of different doses of Remazolam in induction of general anesthesia. 中国当代医药, 2021, 28(28): 122-125.

链接本文:

http://dangdaiyiyao.com/CN/ 或 http://dangdaiyiyao.com/CN/Y2021/V28/I28/122

[1]	余婉秋，李禹琼，朱圣姬，等.苯磺酸瑞马唑仑与丙泊酚用于无痛结肠镜检查的有效性及安全性的随机、单盲、平行对照研究[J].贵州医药，2020，44（6）：846-849.
[2]	徐启明，郭曲练，姚尚龙，等.临床麻醉学[M].北京：人民卫生出版社，2005：10-11，167-173.
[3]	胡千华，周文娟，侯鸣宇，等.静脉注射苯磺酸瑞马唑仑在肥胖患者无痛胃肠镜检查中的应用分析[J].药品评价，2020，17（24）：55-58.
[4]	王晓东，于明涛，刘子强，等.苯磺酸瑞马唑仑联合艾司氯胺酮静脉麻醉在内镜下逆行胰胆管造影术中的临床应用[J].中国医刊，2021，56（3），274-277.
[5]	Ganesh A，Watcha MF.Bispectral index monitoring in pediatric anesthesia[J].Curr Opin Anaesthesiol，2004，17（3）：229-234.
[6]	Wesolowski AM，Zaccagnino MP，Malapero RJ，et al.Remimazolam：Pharmacologic Considerations and Clinical Role in Anesthesiology[J].Pharmacotherapy，2016，36（9）：1021-1027.
[7]	崔守巍.甲苯磺酸瑞马唑仑用于无痛人流手术的临床研究[J].临床医药文献电子杂志，2020，7（96）：145-146.
[8]	Kops MS，Pesic M，Petersen KU，et al.Impact of concurrent remifentanil on the sedative effects of remimazolam，midazolam and propofol in cynomolgus monkeys[J].Eur J Pharmacol，2020，3（5）：890-895.
[9]	Chen W，Chen S，Huang Y.Induction and maintenance of procedural sedation in adults：focus on remimazolam injection[J].Expert Rev Clin Pharmacol，2021，3（17）：1-16.
[10]	Pastis NJ，Yarmus LB，Schippers F，et al.Safety and Efficacy of Remimazolam Compared With Placebo and Midazolam for Moderate Sedation During Bronchoscopy[J]Chest，2019，155（1）：137-146.
[11]	贾真，任丽霞，范叶铁，等.甲苯磺酸瑞马唑仑用于纤维支气管镜检查中深度镇静的有效剂量观察[J].中华医学杂志，2021，101（11）：813-816.
[12]	崔守巍.甲苯磺酸瑞马唑仑用于无痛人流手术的临床研究[J].临床医药文献电子杂志，2020，7（96）：145-146.
[13]	Morimoto Y，Yoshimatsu A，Yoshimura M.Anesthetic management for a patient with myotonic dystrophy with remimazolam[J].JA Clin Rep，2021，7（1）：10-13.
[16]	王春艳，于泳浩.瑞马唑仑临床研究进展[J].中华麻醉学杂志，2019，39（3）：261-263.
[17]	陈瑜，蔡姝，朱晓刚，等.瑞马唑仑用于老年患者全麻诱导时的镇静效果[J].中华麻醉学杂志，2020，40（8）：974-976.
[14]	Yoshida A，Kurata S，Kida K，et al.Anesthetic management for the sleep-awake-sleep technique of awake craniotomy using a novel benzodiazepine remimazolam and its antagonist flumazenil[J].JA Clin Rep，2021，7（1）：14-17.
[15]	Saito K，Ohno S，Maeda M，et al.Remimazolam anesthesia for cardiac surgery with cardiopulmonary bypass： a case report[J].JA Clin Rep，2021，7（1）：21-25.